Jane McLelland: 20+ Years in Remission from Terminal Cervical Cancer and AML Leukemia Through the Starve Cancer Metro Map

During my own battle with stage 4 cancer, one of the biggest questions that kept me and my wife Dr. Jean awake at night was how to stop cancer stem cells from fueling a relapse. We knew that conventional treatments like radiation and chemotherapy can shrink visible tumors, but they often leave behind resistant micro-cells that come back stronger. That search led me to the remarkable story of Jane McLelland, a British physiotherapist and author of How to Starve Cancer.

Jane faced what most oncologists consider an impossible situation: advanced cervical cancer that metastasized to her lungs, followed years later by secondary acute myeloid leukemia (AML) caused by the very chemotherapy used to treat her first cancer. Given only weeks to live, Jane applied her deep medical background to create the famous “Metro Map” of cancer metabolism. More than two decades later, she remains in verified complete remission, living as proof that targeting the fuel lines of cancer can change everything.

The Dual Diagnosis and the Terminal Sentence

Jane was first diagnosed with cervical cancer in 1994 at age 35. She underwent standard surgery and intensive radiotherapy, believing she had put the illness behind her. Five years later, in 1999, persistent chest pain led to CT scans that showed multiple active tumors scattered across both lungs. Her cancer had become metastatic Stage 4.

She agreed to aggressive systemic chemotherapy, but in 2004, blood tests revealed a devastating secondary diagnosis: acute myeloid leukemia (AML), a fast-moving blood cancer caused by the toxic damage of prior chemotherapy. Her oncologists sat her down and gently explained that her body could tolerate no further conventional treatment. She was told to get her affairs in order.

The Breakthrough: Mapping the Fuel Lines of Cancer

Refusing to give up, Jane spent months in medical libraries studying peer-reviewed papers on cellular oncology. She discovered that cancer cells are metabolic scavengers: they cannot thrive on normal cellular respiration, so they rely on four primary energy highways to survive and multiply:

• Glucose (Sugar): Cancer cells consume glucose at up to 200 times the rate of normal cells to generate rapid biomass.
• Glutamine (Amino Acid): Used for cellular nitrogen, protein synthesis, and anti-oxidant defense against chemotherapy.
• Fatty Acids (Lipids): Consumed to build outer cell membranes and supply mitochondrial energy.
• Oxidative Phosphorylation: Backup cellular respiration pathways that allow cancer stem cells to hibernate through harsh environments.

The Metro Map Protocol: Repurposed Medications

Jane realized that developing a new multi-billion dollar cancer drug would take decades, but common, safe, out-of-patent medications already existed that could block each highway simultaneously:

• Metformin: A well-known diabetes medication that suppresses blood glucose, inhibits the mTOR pathway, and cuts insulin-like growth factors.
• Atorvastatin: A common cholesterol-lowering medication that inhibits the mevalonate pathway, preventing cancer cells from manufacturing lipids and cell walls.
• Mebendazole: A gentle antiparasitic medicine that binds to tubulin in cancer cells, inhibiting glucose uptake and inducing selective cell death without damaging healthy tissues.
• Dipyridamole: A blood circulation agent that blocks cellular nucleoside salvage pathways, preventing tumor cells from repairing damaged DNA.
• Botanical Enhancers: High-purity berberine, standardized curcumin, and green tea EGCG to provide broad antioxidant and anti-inflammatory synergy.

Verified Clinical Outcome: 20+ Years NED

Within months of starting her comprehensive metabolic blockade alongside a ketogenic, low-glycemic diet, Jane’s blood counts began normalizing. Her leukemia went into complete remission, and follow-up imaging revealed that the metastatic lesions in her lungs had completely resolved. Today, more than 20 years later, Jane is alive, healthy, and teaching oncologists and patients across the globe how to apply metabolic starve-cancer protocols.

Key Takeaways for Us and for You

When Jean and I evaluate Jane McLelland’s story, three central truths stand out for any patient facing an advanced or recurrent diagnosis:

1. Cancer is a metabolic disease as well as a genetic one: Starving cancer of its preferred metabolic fuels can dramatically enhance the effectiveness of treatments while protecting healthy organs.
2. Repurposed medications offer affordable hope: Powerful interventions do not always require experimental prices. Safe, established drugs with long safety profiles can be repurposed under doctor supervision.
3. Be your own health advocate: Jane survived because she refused to accept a passive death sentence. She asked scientific questions, partnered with open-minded doctors, and took active ownership of her healing.